SA
RARE logo
Ultragenyx Pharmaceutical Inc.(RARE)
Closing price · checked 4:30 PM ETAbout this dataData status
$15.90▼-0.18 (-1.12%)
After Hours:$15.82-0.08 (-0.50%)

Ultragenyx Pharmaceutical Inc. (RARE)

R&D to Revenue

111.44%

Fiscal year · Period ending:

RARE logo

RARE R&D to Revenue

Latest reported111.44%
RARE FY R&D/Revenue (0.00% → 111.44%)
High-resolution chart · PNG

What is r&d to revenue?

R&D spending as percentage of revenue.

RARE r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Ultragenyx Pharmaceutical Inc. R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
111.4413%
124.5676%
149.3265%
194.2562%
141.4754%
152.0437%
344.5581%
570.9253%
8,868.4533%
137,747.3684%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.